In focus · trending topic

Fascioscapulohumeral

1 stories · following the connections

aTyr Pharma Announces Promising Top-Line Results from Resolaris™ Phase 1b/2 Clinical Trial in Patients with Early Onset Facioscapulohumeral Muscular Dystrophy

By Nasdaq OMXApr 24, 2017, 11:30 AM UTC